Pain relieved! Saridon exempted from list of banned FDCs by Supreme Court
Commenting on the court order, PEL Executive Director Nandini Piramal said, "We are pleased with the Supreme Court ruling, as it is an affirmation to our commitment to provide effective and safe healthcare solutions that address unique needs of Indian consumers.
Last year in September, the government had banned 328 FDCs, which were termed 'irrational' on the basis of safety issues and lack of therapeutic justification. Saridon Website